CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating expenses:
Research and development	$ 60,263	$ 57,288
General and administrative	28,719	13,268
Total operating expenses	88,982	70,556
Loss from operations	(88,982)	(70,556)
Other income:
Interest income	13,295	8,170
Other income	419	698
Total other income	13,714	8,868
Net loss	$ (75,268)	$ (61,688)
Net loss per share, basic (in dollars per share)	$ (1.88)	$ (15.99)
Net loss per share, diluted (in dollars per share)	$ (1.88)	$ (15.99)
Weighted-average common shares outstanding, basic (in shares)	39,962,163	3,858,859
Weighted-average common shares outstanding, diluted (in shares)	39,962,163	3,858,859
Comprehensive loss:
Net loss	$ (75,268)	$ (61,688)
Unrealized gain on marketable securities	172	368
Total other comprehensive gain	172	368
Comprehensive loss	$ (75,096)	$ (61,320)